|
1 |
A Real-World Rheumatology Registry and Research Consortium: The German RheumaDatenRhePort (RHADAR) Registry
Kleinert, Stefan. - Würzburg : Universität Würzburg, 2025
|
|
|
|
2 |
A. Kuhn u.a. (Hrsg.): Theoretische Perspektiven und Gegenstände der Buchforschung [Rezension]
Frimmel, Johannes Rezensent, 2025
|
|
|
|
3 |
Challenges and opportunities of power systems from smart homes to super-grids
Kuhn, Philipp. - Ingolstadt : Technische Hochschule Ingolstadt, 2025
|
|
|
|
4 |
Der unerwartete Gast
Kuhn, Mattis. - Mainz : Universitätsbibliothek der Johannes Gutenberg-Universität Mainz, 2025
|
|
|
|
5 |
Digital empowerment on hold: DiGA adoption gaps−a German national cross-sectional patient survey study
Kremer, Phillip. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2025
|
|
|
|
6 |
Drug survival superiority of tumor necrosis factor inhibitors and interleukin-17 inhibitors over Janus kinase inhibitors and interleukin-12/23 inhibitors in German psoriatic arthritis outpatients: retrospective analysis of the RHADAR database
Strunz, Patrick-Pascal. - Würzburg : Universität Würzburg, 2025
|
|
|
|
7 |
Monitoring mental health in esports: requirement analysis and design concepts of an mHealth application
Stolberg, Leona. - Augsburg : Universität Augsburg, 2025
|
|
|
|
8 |
Toward digitally supported self-assessment of patients with idiopathic inflammatory myopathies
Seese, Felix Kurt. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2025
|
|
|
9 |
Buchbesprechungen
Enthalten in Zeitschrift für historische Forschung Bd. 52, 2025, Nr. 2: 297-380
|
|
|
|
10 |
Palbociclib in Combination with either Aromatase Inhibitors or Fulvestrant for Patients with Advanced HR+/HER2− Breast Cancer in Germany: Final Results of the Phase 2 Multicohort INGE-B Trial
Enthalten in Oncology research and treatment Bd. 48, 2025, Nr. 1-2: 14-25. 11 S.
|
|
Administration
